Oxcarbazepine Tablet, Film Coated
Product Images NDC 0904-7593

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 0904-7593). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600mg Carton Label (567c0777 9bc5 45a9 Ba25 959dd76d0e05 00)

Label for Oxcarbazepine tablets USP 600 mg, film coated, oral dosage form. The label shows it is a unit dose package containing 100 tablets, distributed by Major Pharmaceuticals, Indianapolis, IN. It includes storage instructions, a mention that each tablet contains 600 mg oxcarbazepine, and a note that the package is not child-resistant and intended for institutional use only.*

FDA Label Image

300mg Carton Label (567c0777 9bc5 45a9 Ba25 959dd76d0e05 01)

Oxcarbazepine 300 mg film-coated tablets unit dose packaging label by Major Pharmaceuticals. The label shows the product name, strength, and quantity of 100 tablets (10 x 10). It includes NDC 0904-7594-61 and dispensing instructions, along with color additive information, storage conditions, and packaging distributor details.*

FDA Label Image

150mg Carton Label (567c0777 9bc5 45a9 Ba25 959dd76d0e05 02)

The image shows a unit dose packaging label for Oxcarbazepine tablets, USP, 150 mg strength, manufactured by Major Pharmaceuticals. The label includes the NDC 0904-7593-61, quantity of 100 tablets (10 x 10), and instructions to dispense with a medication guide. Additional details include storage conditions, non-child resistant packaging, inclusion of FD&C Yellow No. 5 color additive, and distribution information from Major Pharmaceuticals in Indianapolis, IN. A barcode is also visible.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of oxcarbazepine, showing a dibenzazepine core with a ketone and an amide functional group attached to the nitrogen atom.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A line graph showing exit rates over time from day 2 to day 11 at 8 am comparing two treatment groups: Oxcarbazepine and placebo. The graph includes a log-rank test p-value of 0.0001, indicating statistical comparison between the groups.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A survival curve chart showing seizure rate over time from first dose to first seizure, comparing two treatment groups: Oxcarbazepine and Placebo. The x-axis represents days from first dose to seizure, and the y-axis represents seizure rate. The chart includes a log-rank test p-value of 0.046 indicating statistical comparison between groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier survival curve chart showing exit rate over time (days) for two treatment groups labeled HIGH and LOW. The y-axis represents exit rate from 0 to 1.0, and the x-axis represents time to exit in days from 0 to 130. The LOW group (dotted line) shows a higher exit rate over time compared to the HIGH group (solid line), with a log-rank test p-value of 0.0001.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival curve graph showing exit rate over time (days) comparing two treatment groups labeled HIGH and LOW. The y-axis represents the exit rate from 0.0 to 1.0, and the x-axis represents time to exit in days from 0 to 130. The LOW group exhibits a faster increase in exit rate than the HIGH group, with a significant log-rank test p-value of 0.0001 indicated on the graph.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.